AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2018
Sep 19, 2018
35086_dirs_2018-09-19_0f278963-6883-4cf0-9b41-c9e72f46ff2a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-09-17
Reporting Person: DOYLE WILLIAM F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-17 | Common Stock | P | 1800 | $10.50 | Acquired | 12011 | Direct |
More from Minerva Neurosciences, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17